Cargando…
Type 2 Diabetes and Heart Failure: Challenges and Solutions
Increasing numbers of older patients with type 2 diabetes, and their improved survival from cardiovascular events is seeing a massive increase in patients with both diabetes and heart failure. Already, at least a third of all patients with heart failure have diabetes. This close association is partl...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011193/ https://www.ncbi.nlm.nih.gov/pubmed/27280301 http://dx.doi.org/10.2174/1573403X12666160606120254 |
_version_ | 1782451781522948096 |
---|---|
author | Thomas, Merlin C. |
author_facet | Thomas, Merlin C. |
author_sort | Thomas, Merlin C. |
collection | PubMed |
description | Increasing numbers of older patients with type 2 diabetes, and their improved survival from cardiovascular events is seeing a massive increase in patients with both diabetes and heart failure. Already, at least a third of all patients with heart failure have diabetes. This close association is partly because all the major risk factors for heart failure also cluster in patients with type 2 diabetes, including obesity, hypertension, advanced age, sleep apnoea, dyslipidaemia, anaemia, chronic kidney disease, and coronary heart disease. However, diabetes may also cause cardiac dysfunction in the absence of overt macrovascular disease, as well as complicate the response to therapy. Current management is focused on targeting modifiable risk factors for heart failure including hyperglycaemia, dyslipidaemia, hypertension, obesity and anemia. But although these are important risk markers, none of these interventions substantially prevents heart failure or improves its outcomes. Much more needs to be done to focus on this issue, including the inclusion of hospital admission for heart failure as a pre-specified component of the primary composite cardiovascular outcomes and new trials in heart failure management specifically in the context of diabetes. |
format | Online Article Text |
id | pubmed-5011193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-50111932017-08-01 Type 2 Diabetes and Heart Failure: Challenges and Solutions Thomas, Merlin C. Curr Cardiol Rev Article Increasing numbers of older patients with type 2 diabetes, and their improved survival from cardiovascular events is seeing a massive increase in patients with both diabetes and heart failure. Already, at least a third of all patients with heart failure have diabetes. This close association is partly because all the major risk factors for heart failure also cluster in patients with type 2 diabetes, including obesity, hypertension, advanced age, sleep apnoea, dyslipidaemia, anaemia, chronic kidney disease, and coronary heart disease. However, diabetes may also cause cardiac dysfunction in the absence of overt macrovascular disease, as well as complicate the response to therapy. Current management is focused on targeting modifiable risk factors for heart failure including hyperglycaemia, dyslipidaemia, hypertension, obesity and anemia. But although these are important risk markers, none of these interventions substantially prevents heart failure or improves its outcomes. Much more needs to be done to focus on this issue, including the inclusion of hospital admission for heart failure as a pre-specified component of the primary composite cardiovascular outcomes and new trials in heart failure management specifically in the context of diabetes. Bentham Science Publishers 2016-08 2016-08 /pmc/articles/PMC5011193/ /pubmed/27280301 http://dx.doi.org/10.2174/1573403X12666160606120254 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Thomas, Merlin C. Type 2 Diabetes and Heart Failure: Challenges and Solutions |
title | Type 2 Diabetes and Heart Failure: Challenges and Solutions |
title_full | Type 2 Diabetes and Heart Failure: Challenges and Solutions |
title_fullStr | Type 2 Diabetes and Heart Failure: Challenges and Solutions |
title_full_unstemmed | Type 2 Diabetes and Heart Failure: Challenges and Solutions |
title_short | Type 2 Diabetes and Heart Failure: Challenges and Solutions |
title_sort | type 2 diabetes and heart failure: challenges and solutions |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011193/ https://www.ncbi.nlm.nih.gov/pubmed/27280301 http://dx.doi.org/10.2174/1573403X12666160606120254 |
work_keys_str_mv | AT thomasmerlinc type2diabetesandheartfailurechallengesandsolutions |